Canaccord Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Go back to Canaccord Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 243.71 -6.97 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $250.68 | 52 Week High | $160.00 | |||
| Open | $250.13 | 52 Week Low | $95.80 | |||
| Day High | $252.50 | P/E | 45.30 | |||
| Day Low | $243.02 | EPS | $5.38 | |||
| Volume | 1,072,822 | |||||
